Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.

Araujo AM, Abaurrea A, Azcoaga P, López-Velazco JI, Manzano S, Rodriguez J, Rezola R, Egia-Mendikute L, Valdés-Mora F, Flores JM, Jenkins L, Pulido L, Osorio-Querejeta I, Fernández-Nogueira P, Ferrari N, Viera C, Martín-Martín N, Tzankov A, Eppenberger-Castori S, Alvarez-Lopez I, Urruticoechea A, Bragado P, Coleman N, Palazón A, Carracedo A, Gallego-Ortega D, Calvo F, Isacke CM, Caffarel MM, Lawrie CH

Open source

DOI: 10.1172/jci148667
Published: 2022 Apr 1
Container: The Journal of clinical investigation
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci148667,
  title = {Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.},
  author = {Araujo AM and Abaurrea A and Azcoaga P and López-Velazco JI and Manzano S and Rodriguez J and Rezola R and Egia-Mendikute L and Valdés-Mora F and Flores JM and Jenkins L and Pulido L and Osorio-Querejeta I and Fernández-Nogueira P and Ferrari N and Viera C and Martín-Martín N and Tzankov A and Eppenberger-Castori S and Alvarez-Lopez I and Urruticoechea A and Bragado P and Coleman N and Palazón A and Carracedo A and Gallego-Ortega D and Calvo F and Isacke CM and Caffarel MM and Lawrie CH},
  year = {2022},
  journal = {The Journal of clinical investigation},
  doi = {10.1172/jci148667},
  url = {https://doi.org/10.1172/jci148667}
}

RIS

TY  - JOUR
TI  - Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.
AU  - Araujo AM
AU  - Abaurrea A
AU  - Azcoaga P
AU  - López-Velazco JI
AU  - Manzano S
AU  - Rodriguez J
AU  - Rezola R
AU  - Egia-Mendikute L
AU  - Valdés-Mora F
AU  - Flores JM
AU  - Jenkins L
AU  - Pulido L
AU  - Osorio-Querejeta I
AU  - Fernández-Nogueira P
AU  - Ferrari N
AU  - Viera C
AU  - Martín-Martín N
AU  - Tzankov A
AU  - Eppenberger-Castori S
AU  - Alvarez-Lopez I
AU  - Urruticoechea A
AU  - Bragado P
AU  - Coleman N
AU  - Palazón A
AU  - Carracedo A
AU  - Gallego-Ortega D
AU  - Calvo F
AU  - Isacke CM
AU  - Caffarel MM
AU  - Lawrie CH
PY  - 2022
JO  - The Journal of clinical investigation
DO  - 10.1172/jci148667
UR  - https://doi.org/10.1172/jci148667
ER  -

APA

AM, A., A, A., P, A., JI, L., S, M., J, R., R, R., L, E., F, V., JM, F., L, J., L, P., I, O., P, F., N, F., C, V., N, M., A, T., S, E., I, A., A, U., P, B., N, C., A, P., A, C., D, G., F, C., CM, I., MM, C., & CH, L. (2022). Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.. The Journal of clinical investigation. https://doi.org/10.1172/jci148667

Source records

pubmed · retrieved 2026-09-25T18:03:40.183Z
europe-pmc · retrieved 2026-09-25T18:03:40.198Z
europe-pmc · retrieved 2026-09-25T18:03:40.198Z